Research ArticleArticle
The Prevalence of Rheumatoid Arthritis in Chile: A Nationwide Study Performed as Part of the National Health Survey
Josefina Durán, Loreto Massardo, Carolina Llanos, Sergio Iacobelli, Paula Burgos, Marcela Cisternas, Mirentxu Iruretagoyena, Macarena Armstrong, Raquel Aguilera, Francisco Radrigán, María Eugenia Martinez, Alvaro Passi-Solar, Pablo Riedemann, Natalia Crisóstomo, Camila Cifuentes, Lucero Hagedorn, Alvaro Cisternas, Nancy Vasquez, Paula Margozzini and the ENS2017 Study Group
The Journal of Rheumatology September 2019, jrheum.190396; DOI: https://doi.org/10.3899/jrheum.190396
Josefina Durán
From the Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile, Santiago; Centro de Biología Celular y Biomedicina, Facultad de Medicina y Ciencia, Universidad San Sebastián, Santiago; Hospital Dr. Sótero del Río, Pontificia Universidad Católica de Chile, Santiago; Department of Public Health, School of Medicine, Pontificia Universidad Católica de Chile, Santiago; Department of Rheumatology, School of Medicine, Universidad de la Frontera, Temuco, Chile; Department of Epidemiology and Public Health, University College London, London, UK. Funded by the Chilean Ministry of Health (MINSAL) and by the Rheumatology Department of Pontificia Universidad Católica de Chile. J. Durán, MD, MS, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; L. Massardo, MD, Centro de Biología Celular y Biomedicina, Facultad de Medicina y Ciencia, Universidad San Sebastián; C. Llanos, MD, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; S. Iacobelli, MD, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; P.I. Burgos, MD, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; M. Cisternas, MD, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; M. Iruretagoyena, MD, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; M. Armstrong, MD, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; R. Aguilera, MD, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; F. Radrigán, MD, Hospital Dr. Sótero del Río, Pontificia Universidad Católica de Chile; M.E. Martinez, MD, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; A. Passi-Solar, MS, Department of Epidemiology and Public Health, University College London, and Department of Public Health, School of Medicine, Pontificia Universidad Católica de Chile; P. Riedemann, MD, MPH, Department of Rheumatology, School of Medicine, Universidad de la Frontera; N. Crisóstomo, School of Medicine, Pontificia Universidad Católica de Chile; C. Cifuentes, MD, School of Medicine, Pontificia Universidad Católica de Chile; L. Hagedorn, School of Medicine, Pontificia Universidad Católica de Chile; A. Cisternas, MD, School of Medicine, Pontificia Universidad Católica de Chile; N. Vasquez, RN, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; P. Margozzini, MD, MPH, Department of Epidemiology and Public Health, University College London. Address correspondence to Drs. J. Durán and P. Margozzini, Diagonal Paraguay 362, 6th floor, Santiago Centro, Santiago, Chile. E-mail: jgduran@uc.cl, pmargoz@med.puc.cl. Accepted for publication August 22, 2019.
Loreto Massardo
From the Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile, Santiago; Centro de Biología Celular y Biomedicina, Facultad de Medicina y Ciencia, Universidad San Sebastián, Santiago; Hospital Dr. Sótero del Río, Pontificia Universidad Católica de Chile, Santiago; Department of Public Health, School of Medicine, Pontificia Universidad Católica de Chile, Santiago; Department of Rheumatology, School of Medicine, Universidad de la Frontera, Temuco, Chile; Department of Epidemiology and Public Health, University College London, London, UK. Funded by the Chilean Ministry of Health (MINSAL) and by the Rheumatology Department of Pontificia Universidad Católica de Chile. J. Durán, MD, MS, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; L. Massardo, MD, Centro de Biología Celular y Biomedicina, Facultad de Medicina y Ciencia, Universidad San Sebastián; C. Llanos, MD, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; S. Iacobelli, MD, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; P.I. Burgos, MD, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; M. Cisternas, MD, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; M. Iruretagoyena, MD, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; M. Armstrong, MD, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; R. Aguilera, MD, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; F. Radrigán, MD, Hospital Dr. Sótero del Río, Pontificia Universidad Católica de Chile; M.E. Martinez, MD, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; A. Passi-Solar, MS, Department of Epidemiology and Public Health, University College London, and Department of Public Health, School of Medicine, Pontificia Universidad Católica de Chile; P. Riedemann, MD, MPH, Department of Rheumatology, School of Medicine, Universidad de la Frontera; N. Crisóstomo, School of Medicine, Pontificia Universidad Católica de Chile; C. Cifuentes, MD, School of Medicine, Pontificia Universidad Católica de Chile; L. Hagedorn, School of Medicine, Pontificia Universidad Católica de Chile; A. Cisternas, MD, School of Medicine, Pontificia Universidad Católica de Chile; N. Vasquez, RN, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; P. Margozzini, MD, MPH, Department of Epidemiology and Public Health, University College London. Address correspondence to Drs. J. Durán and P. Margozzini, Diagonal Paraguay 362, 6th floor, Santiago Centro, Santiago, Chile. E-mail: jgduran@uc.cl, pmargoz@med.puc.cl. Accepted for publication August 22, 2019.
Carolina Llanos
From the Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile, Santiago; Centro de Biología Celular y Biomedicina, Facultad de Medicina y Ciencia, Universidad San Sebastián, Santiago; Hospital Dr. Sótero del Río, Pontificia Universidad Católica de Chile, Santiago; Department of Public Health, School of Medicine, Pontificia Universidad Católica de Chile, Santiago; Department of Rheumatology, School of Medicine, Universidad de la Frontera, Temuco, Chile; Department of Epidemiology and Public Health, University College London, London, UK. Funded by the Chilean Ministry of Health (MINSAL) and by the Rheumatology Department of Pontificia Universidad Católica de Chile. J. Durán, MD, MS, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; L. Massardo, MD, Centro de Biología Celular y Biomedicina, Facultad de Medicina y Ciencia, Universidad San Sebastián; C. Llanos, MD, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; S. Iacobelli, MD, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; P.I. Burgos, MD, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; M. Cisternas, MD, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; M. Iruretagoyena, MD, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; M. Armstrong, MD, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; R. Aguilera, MD, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; F. Radrigán, MD, Hospital Dr. Sótero del Río, Pontificia Universidad Católica de Chile; M.E. Martinez, MD, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; A. Passi-Solar, MS, Department of Epidemiology and Public Health, University College London, and Department of Public Health, School of Medicine, Pontificia Universidad Católica de Chile; P. Riedemann, MD, MPH, Department of Rheumatology, School of Medicine, Universidad de la Frontera; N. Crisóstomo, School of Medicine, Pontificia Universidad Católica de Chile; C. Cifuentes, MD, School of Medicine, Pontificia Universidad Católica de Chile; L. Hagedorn, School of Medicine, Pontificia Universidad Católica de Chile; A. Cisternas, MD, School of Medicine, Pontificia Universidad Católica de Chile; N. Vasquez, RN, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; P. Margozzini, MD, MPH, Department of Epidemiology and Public Health, University College London. Address correspondence to Drs. J. Durán and P. Margozzini, Diagonal Paraguay 362, 6th floor, Santiago Centro, Santiago, Chile. E-mail: jgduran@uc.cl, pmargoz@med.puc.cl. Accepted for publication August 22, 2019.
Sergio Iacobelli
From the Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile, Santiago; Centro de Biología Celular y Biomedicina, Facultad de Medicina y Ciencia, Universidad San Sebastián, Santiago; Hospital Dr. Sótero del Río, Pontificia Universidad Católica de Chile, Santiago; Department of Public Health, School of Medicine, Pontificia Universidad Católica de Chile, Santiago; Department of Rheumatology, School of Medicine, Universidad de la Frontera, Temuco, Chile; Department of Epidemiology and Public Health, University College London, London, UK. Funded by the Chilean Ministry of Health (MINSAL) and by the Rheumatology Department of Pontificia Universidad Católica de Chile. J. Durán, MD, MS, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; L. Massardo, MD, Centro de Biología Celular y Biomedicina, Facultad de Medicina y Ciencia, Universidad San Sebastián; C. Llanos, MD, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; S. Iacobelli, MD, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; P.I. Burgos, MD, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; M. Cisternas, MD, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; M. Iruretagoyena, MD, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; M. Armstrong, MD, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; R. Aguilera, MD, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; F. Radrigán, MD, Hospital Dr. Sótero del Río, Pontificia Universidad Católica de Chile; M.E. Martinez, MD, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; A. Passi-Solar, MS, Department of Epidemiology and Public Health, University College London, and Department of Public Health, School of Medicine, Pontificia Universidad Católica de Chile; P. Riedemann, MD, MPH, Department of Rheumatology, School of Medicine, Universidad de la Frontera; N. Crisóstomo, School of Medicine, Pontificia Universidad Católica de Chile; C. Cifuentes, MD, School of Medicine, Pontificia Universidad Católica de Chile; L. Hagedorn, School of Medicine, Pontificia Universidad Católica de Chile; A. Cisternas, MD, School of Medicine, Pontificia Universidad Católica de Chile; N. Vasquez, RN, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; P. Margozzini, MD, MPH, Department of Epidemiology and Public Health, University College London. Address correspondence to Drs. J. Durán and P. Margozzini, Diagonal Paraguay 362, 6th floor, Santiago Centro, Santiago, Chile. E-mail: jgduran@uc.cl, pmargoz@med.puc.cl. Accepted for publication August 22, 2019.
Paula Burgos
From the Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile, Santiago; Centro de Biología Celular y Biomedicina, Facultad de Medicina y Ciencia, Universidad San Sebastián, Santiago; Hospital Dr. Sótero del Río, Pontificia Universidad Católica de Chile, Santiago; Department of Public Health, School of Medicine, Pontificia Universidad Católica de Chile, Santiago; Department of Rheumatology, School of Medicine, Universidad de la Frontera, Temuco, Chile; Department of Epidemiology and Public Health, University College London, London, UK. Funded by the Chilean Ministry of Health (MINSAL) and by the Rheumatology Department of Pontificia Universidad Católica de Chile. J. Durán, MD, MS, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; L. Massardo, MD, Centro de Biología Celular y Biomedicina, Facultad de Medicina y Ciencia, Universidad San Sebastián; C. Llanos, MD, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; S. Iacobelli, MD, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; P.I. Burgos, MD, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; M. Cisternas, MD, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; M. Iruretagoyena, MD, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; M. Armstrong, MD, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; R. Aguilera, MD, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; F. Radrigán, MD, Hospital Dr. Sótero del Río, Pontificia Universidad Católica de Chile; M.E. Martinez, MD, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; A. Passi-Solar, MS, Department of Epidemiology and Public Health, University College London, and Department of Public Health, School of Medicine, Pontificia Universidad Católica de Chile; P. Riedemann, MD, MPH, Department of Rheumatology, School of Medicine, Universidad de la Frontera; N. Crisóstomo, School of Medicine, Pontificia Universidad Católica de Chile; C. Cifuentes, MD, School of Medicine, Pontificia Universidad Católica de Chile; L. Hagedorn, School of Medicine, Pontificia Universidad Católica de Chile; A. Cisternas, MD, School of Medicine, Pontificia Universidad Católica de Chile; N. Vasquez, RN, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; P. Margozzini, MD, MPH, Department of Epidemiology and Public Health, University College London. Address correspondence to Drs. J. Durán and P. Margozzini, Diagonal Paraguay 362, 6th floor, Santiago Centro, Santiago, Chile. E-mail: jgduran@uc.cl, pmargoz@med.puc.cl. Accepted for publication August 22, 2019.
Marcela Cisternas
From the Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile, Santiago; Centro de Biología Celular y Biomedicina, Facultad de Medicina y Ciencia, Universidad San Sebastián, Santiago; Hospital Dr. Sótero del Río, Pontificia Universidad Católica de Chile, Santiago; Department of Public Health, School of Medicine, Pontificia Universidad Católica de Chile, Santiago; Department of Rheumatology, School of Medicine, Universidad de la Frontera, Temuco, Chile; Department of Epidemiology and Public Health, University College London, London, UK. Funded by the Chilean Ministry of Health (MINSAL) and by the Rheumatology Department of Pontificia Universidad Católica de Chile. J. Durán, MD, MS, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; L. Massardo, MD, Centro de Biología Celular y Biomedicina, Facultad de Medicina y Ciencia, Universidad San Sebastián; C. Llanos, MD, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; S. Iacobelli, MD, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; P.I. Burgos, MD, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; M. Cisternas, MD, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; M. Iruretagoyena, MD, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; M. Armstrong, MD, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; R. Aguilera, MD, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; F. Radrigán, MD, Hospital Dr. Sótero del Río, Pontificia Universidad Católica de Chile; M.E. Martinez, MD, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; A. Passi-Solar, MS, Department of Epidemiology and Public Health, University College London, and Department of Public Health, School of Medicine, Pontificia Universidad Católica de Chile; P. Riedemann, MD, MPH, Department of Rheumatology, School of Medicine, Universidad de la Frontera; N. Crisóstomo, School of Medicine, Pontificia Universidad Católica de Chile; C. Cifuentes, MD, School of Medicine, Pontificia Universidad Católica de Chile; L. Hagedorn, School of Medicine, Pontificia Universidad Católica de Chile; A. Cisternas, MD, School of Medicine, Pontificia Universidad Católica de Chile; N. Vasquez, RN, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; P. Margozzini, MD, MPH, Department of Epidemiology and Public Health, University College London. Address correspondence to Drs. J. Durán and P. Margozzini, Diagonal Paraguay 362, 6th floor, Santiago Centro, Santiago, Chile. E-mail: jgduran@uc.cl, pmargoz@med.puc.cl. Accepted for publication August 22, 2019.
Mirentxu Iruretagoyena
From the Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile, Santiago; Centro de Biología Celular y Biomedicina, Facultad de Medicina y Ciencia, Universidad San Sebastián, Santiago; Hospital Dr. Sótero del Río, Pontificia Universidad Católica de Chile, Santiago; Department of Public Health, School of Medicine, Pontificia Universidad Católica de Chile, Santiago; Department of Rheumatology, School of Medicine, Universidad de la Frontera, Temuco, Chile; Department of Epidemiology and Public Health, University College London, London, UK. Funded by the Chilean Ministry of Health (MINSAL) and by the Rheumatology Department of Pontificia Universidad Católica de Chile. J. Durán, MD, MS, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; L. Massardo, MD, Centro de Biología Celular y Biomedicina, Facultad de Medicina y Ciencia, Universidad San Sebastián; C. Llanos, MD, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; S. Iacobelli, MD, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; P.I. Burgos, MD, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; M. Cisternas, MD, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; M. Iruretagoyena, MD, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; M. Armstrong, MD, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; R. Aguilera, MD, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; F. Radrigán, MD, Hospital Dr. Sótero del Río, Pontificia Universidad Católica de Chile; M.E. Martinez, MD, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; A. Passi-Solar, MS, Department of Epidemiology and Public Health, University College London, and Department of Public Health, School of Medicine, Pontificia Universidad Católica de Chile; P. Riedemann, MD, MPH, Department of Rheumatology, School of Medicine, Universidad de la Frontera; N. Crisóstomo, School of Medicine, Pontificia Universidad Católica de Chile; C. Cifuentes, MD, School of Medicine, Pontificia Universidad Católica de Chile; L. Hagedorn, School of Medicine, Pontificia Universidad Católica de Chile; A. Cisternas, MD, School of Medicine, Pontificia Universidad Católica de Chile; N. Vasquez, RN, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; P. Margozzini, MD, MPH, Department of Epidemiology and Public Health, University College London. Address correspondence to Drs. J. Durán and P. Margozzini, Diagonal Paraguay 362, 6th floor, Santiago Centro, Santiago, Chile. E-mail: jgduran@uc.cl, pmargoz@med.puc.cl. Accepted for publication August 22, 2019.
Macarena Armstrong
From the Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile, Santiago; Centro de Biología Celular y Biomedicina, Facultad de Medicina y Ciencia, Universidad San Sebastián, Santiago; Hospital Dr. Sótero del Río, Pontificia Universidad Católica de Chile, Santiago; Department of Public Health, School of Medicine, Pontificia Universidad Católica de Chile, Santiago; Department of Rheumatology, School of Medicine, Universidad de la Frontera, Temuco, Chile; Department of Epidemiology and Public Health, University College London, London, UK. Funded by the Chilean Ministry of Health (MINSAL) and by the Rheumatology Department of Pontificia Universidad Católica de Chile. J. Durán, MD, MS, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; L. Massardo, MD, Centro de Biología Celular y Biomedicina, Facultad de Medicina y Ciencia, Universidad San Sebastián; C. Llanos, MD, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; S. Iacobelli, MD, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; P.I. Burgos, MD, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; M. Cisternas, MD, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; M. Iruretagoyena, MD, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; M. Armstrong, MD, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; R. Aguilera, MD, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; F. Radrigán, MD, Hospital Dr. Sótero del Río, Pontificia Universidad Católica de Chile; M.E. Martinez, MD, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; A. Passi-Solar, MS, Department of Epidemiology and Public Health, University College London, and Department of Public Health, School of Medicine, Pontificia Universidad Católica de Chile; P. Riedemann, MD, MPH, Department of Rheumatology, School of Medicine, Universidad de la Frontera; N. Crisóstomo, School of Medicine, Pontificia Universidad Católica de Chile; C. Cifuentes, MD, School of Medicine, Pontificia Universidad Católica de Chile; L. Hagedorn, School of Medicine, Pontificia Universidad Católica de Chile; A. Cisternas, MD, School of Medicine, Pontificia Universidad Católica de Chile; N. Vasquez, RN, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; P. Margozzini, MD, MPH, Department of Epidemiology and Public Health, University College London. Address correspondence to Drs. J. Durán and P. Margozzini, Diagonal Paraguay 362, 6th floor, Santiago Centro, Santiago, Chile. E-mail: jgduran@uc.cl, pmargoz@med.puc.cl. Accepted for publication August 22, 2019.
Raquel Aguilera
From the Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile, Santiago; Centro de Biología Celular y Biomedicina, Facultad de Medicina y Ciencia, Universidad San Sebastián, Santiago; Hospital Dr. Sótero del Río, Pontificia Universidad Católica de Chile, Santiago; Department of Public Health, School of Medicine, Pontificia Universidad Católica de Chile, Santiago; Department of Rheumatology, School of Medicine, Universidad de la Frontera, Temuco, Chile; Department of Epidemiology and Public Health, University College London, London, UK. Funded by the Chilean Ministry of Health (MINSAL) and by the Rheumatology Department of Pontificia Universidad Católica de Chile. J. Durán, MD, MS, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; L. Massardo, MD, Centro de Biología Celular y Biomedicina, Facultad de Medicina y Ciencia, Universidad San Sebastián; C. Llanos, MD, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; S. Iacobelli, MD, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; P.I. Burgos, MD, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; M. Cisternas, MD, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; M. Iruretagoyena, MD, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; M. Armstrong, MD, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; R. Aguilera, MD, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; F. Radrigán, MD, Hospital Dr. Sótero del Río, Pontificia Universidad Católica de Chile; M.E. Martinez, MD, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; A. Passi-Solar, MS, Department of Epidemiology and Public Health, University College London, and Department of Public Health, School of Medicine, Pontificia Universidad Católica de Chile; P. Riedemann, MD, MPH, Department of Rheumatology, School of Medicine, Universidad de la Frontera; N. Crisóstomo, School of Medicine, Pontificia Universidad Católica de Chile; C. Cifuentes, MD, School of Medicine, Pontificia Universidad Católica de Chile; L. Hagedorn, School of Medicine, Pontificia Universidad Católica de Chile; A. Cisternas, MD, School of Medicine, Pontificia Universidad Católica de Chile; N. Vasquez, RN, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; P. Margozzini, MD, MPH, Department of Epidemiology and Public Health, University College London. Address correspondence to Drs. J. Durán and P. Margozzini, Diagonal Paraguay 362, 6th floor, Santiago Centro, Santiago, Chile. E-mail: jgduran@uc.cl, pmargoz@med.puc.cl. Accepted for publication August 22, 2019.
Francisco Radrigán
From the Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile, Santiago; Centro de Biología Celular y Biomedicina, Facultad de Medicina y Ciencia, Universidad San Sebastián, Santiago; Hospital Dr. Sótero del Río, Pontificia Universidad Católica de Chile, Santiago; Department of Public Health, School of Medicine, Pontificia Universidad Católica de Chile, Santiago; Department of Rheumatology, School of Medicine, Universidad de la Frontera, Temuco, Chile; Department of Epidemiology and Public Health, University College London, London, UK. Funded by the Chilean Ministry of Health (MINSAL) and by the Rheumatology Department of Pontificia Universidad Católica de Chile. J. Durán, MD, MS, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; L. Massardo, MD, Centro de Biología Celular y Biomedicina, Facultad de Medicina y Ciencia, Universidad San Sebastián; C. Llanos, MD, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; S. Iacobelli, MD, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; P.I. Burgos, MD, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; M. Cisternas, MD, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; M. Iruretagoyena, MD, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; M. Armstrong, MD, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; R. Aguilera, MD, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; F. Radrigán, MD, Hospital Dr. Sótero del Río, Pontificia Universidad Católica de Chile; M.E. Martinez, MD, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; A. Passi-Solar, MS, Department of Epidemiology and Public Health, University College London, and Department of Public Health, School of Medicine, Pontificia Universidad Católica de Chile; P. Riedemann, MD, MPH, Department of Rheumatology, School of Medicine, Universidad de la Frontera; N. Crisóstomo, School of Medicine, Pontificia Universidad Católica de Chile; C. Cifuentes, MD, School of Medicine, Pontificia Universidad Católica de Chile; L. Hagedorn, School of Medicine, Pontificia Universidad Católica de Chile; A. Cisternas, MD, School of Medicine, Pontificia Universidad Católica de Chile; N. Vasquez, RN, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; P. Margozzini, MD, MPH, Department of Epidemiology and Public Health, University College London. Address correspondence to Drs. J. Durán and P. Margozzini, Diagonal Paraguay 362, 6th floor, Santiago Centro, Santiago, Chile. E-mail: jgduran@uc.cl, pmargoz@med.puc.cl. Accepted for publication August 22, 2019.
María Eugenia Martinez
From the Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile, Santiago; Centro de Biología Celular y Biomedicina, Facultad de Medicina y Ciencia, Universidad San Sebastián, Santiago; Hospital Dr. Sótero del Río, Pontificia Universidad Católica de Chile, Santiago; Department of Public Health, School of Medicine, Pontificia Universidad Católica de Chile, Santiago; Department of Rheumatology, School of Medicine, Universidad de la Frontera, Temuco, Chile; Department of Epidemiology and Public Health, University College London, London, UK. Funded by the Chilean Ministry of Health (MINSAL) and by the Rheumatology Department of Pontificia Universidad Católica de Chile. J. Durán, MD, MS, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; L. Massardo, MD, Centro de Biología Celular y Biomedicina, Facultad de Medicina y Ciencia, Universidad San Sebastián; C. Llanos, MD, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; S. Iacobelli, MD, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; P.I. Burgos, MD, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; M. Cisternas, MD, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; M. Iruretagoyena, MD, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; M. Armstrong, MD, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; R. Aguilera, MD, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; F. Radrigán, MD, Hospital Dr. Sótero del Río, Pontificia Universidad Católica de Chile; M.E. Martinez, MD, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; A. Passi-Solar, MS, Department of Epidemiology and Public Health, University College London, and Department of Public Health, School of Medicine, Pontificia Universidad Católica de Chile; P. Riedemann, MD, MPH, Department of Rheumatology, School of Medicine, Universidad de la Frontera; N. Crisóstomo, School of Medicine, Pontificia Universidad Católica de Chile; C. Cifuentes, MD, School of Medicine, Pontificia Universidad Católica de Chile; L. Hagedorn, School of Medicine, Pontificia Universidad Católica de Chile; A. Cisternas, MD, School of Medicine, Pontificia Universidad Católica de Chile; N. Vasquez, RN, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; P. Margozzini, MD, MPH, Department of Epidemiology and Public Health, University College London. Address correspondence to Drs. J. Durán and P. Margozzini, Diagonal Paraguay 362, 6th floor, Santiago Centro, Santiago, Chile. E-mail: jgduran@uc.cl, pmargoz@med.puc.cl. Accepted for publication August 22, 2019.
Alvaro Passi-Solar
From the Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile, Santiago; Centro de Biología Celular y Biomedicina, Facultad de Medicina y Ciencia, Universidad San Sebastián, Santiago; Hospital Dr. Sótero del Río, Pontificia Universidad Católica de Chile, Santiago; Department of Public Health, School of Medicine, Pontificia Universidad Católica de Chile, Santiago; Department of Rheumatology, School of Medicine, Universidad de la Frontera, Temuco, Chile; Department of Epidemiology and Public Health, University College London, London, UK. Funded by the Chilean Ministry of Health (MINSAL) and by the Rheumatology Department of Pontificia Universidad Católica de Chile. J. Durán, MD, MS, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; L. Massardo, MD, Centro de Biología Celular y Biomedicina, Facultad de Medicina y Ciencia, Universidad San Sebastián; C. Llanos, MD, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; S. Iacobelli, MD, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; P.I. Burgos, MD, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; M. Cisternas, MD, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; M. Iruretagoyena, MD, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; M. Armstrong, MD, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; R. Aguilera, MD, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; F. Radrigán, MD, Hospital Dr. Sótero del Río, Pontificia Universidad Católica de Chile; M.E. Martinez, MD, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; A. Passi-Solar, MS, Department of Epidemiology and Public Health, University College London, and Department of Public Health, School of Medicine, Pontificia Universidad Católica de Chile; P. Riedemann, MD, MPH, Department of Rheumatology, School of Medicine, Universidad de la Frontera; N. Crisóstomo, School of Medicine, Pontificia Universidad Católica de Chile; C. Cifuentes, MD, School of Medicine, Pontificia Universidad Católica de Chile; L. Hagedorn, School of Medicine, Pontificia Universidad Católica de Chile; A. Cisternas, MD, School of Medicine, Pontificia Universidad Católica de Chile; N. Vasquez, RN, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; P. Margozzini, MD, MPH, Department of Epidemiology and Public Health, University College London. Address correspondence to Drs. J. Durán and P. Margozzini, Diagonal Paraguay 362, 6th floor, Santiago Centro, Santiago, Chile. E-mail: jgduran@uc.cl, pmargoz@med.puc.cl. Accepted for publication August 22, 2019.
Pablo Riedemann
From the Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile, Santiago; Centro de Biología Celular y Biomedicina, Facultad de Medicina y Ciencia, Universidad San Sebastián, Santiago; Hospital Dr. Sótero del Río, Pontificia Universidad Católica de Chile, Santiago; Department of Public Health, School of Medicine, Pontificia Universidad Católica de Chile, Santiago; Department of Rheumatology, School of Medicine, Universidad de la Frontera, Temuco, Chile; Department of Epidemiology and Public Health, University College London, London, UK. Funded by the Chilean Ministry of Health (MINSAL) and by the Rheumatology Department of Pontificia Universidad Católica de Chile. J. Durán, MD, MS, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; L. Massardo, MD, Centro de Biología Celular y Biomedicina, Facultad de Medicina y Ciencia, Universidad San Sebastián; C. Llanos, MD, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; S. Iacobelli, MD, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; P.I. Burgos, MD, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; M. Cisternas, MD, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; M. Iruretagoyena, MD, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; M. Armstrong, MD, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; R. Aguilera, MD, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; F. Radrigán, MD, Hospital Dr. Sótero del Río, Pontificia Universidad Católica de Chile; M.E. Martinez, MD, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; A. Passi-Solar, MS, Department of Epidemiology and Public Health, University College London, and Department of Public Health, School of Medicine, Pontificia Universidad Católica de Chile; P. Riedemann, MD, MPH, Department of Rheumatology, School of Medicine, Universidad de la Frontera; N. Crisóstomo, School of Medicine, Pontificia Universidad Católica de Chile; C. Cifuentes, MD, School of Medicine, Pontificia Universidad Católica de Chile; L. Hagedorn, School of Medicine, Pontificia Universidad Católica de Chile; A. Cisternas, MD, School of Medicine, Pontificia Universidad Católica de Chile; N. Vasquez, RN, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; P. Margozzini, MD, MPH, Department of Epidemiology and Public Health, University College London. Address correspondence to Drs. J. Durán and P. Margozzini, Diagonal Paraguay 362, 6th floor, Santiago Centro, Santiago, Chile. E-mail: jgduran@uc.cl, pmargoz@med.puc.cl. Accepted for publication August 22, 2019.
Natalia Crisóstomo
From the Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile, Santiago; Centro de Biología Celular y Biomedicina, Facultad de Medicina y Ciencia, Universidad San Sebastián, Santiago; Hospital Dr. Sótero del Río, Pontificia Universidad Católica de Chile, Santiago; Department of Public Health, School of Medicine, Pontificia Universidad Católica de Chile, Santiago; Department of Rheumatology, School of Medicine, Universidad de la Frontera, Temuco, Chile; Department of Epidemiology and Public Health, University College London, London, UK. Funded by the Chilean Ministry of Health (MINSAL) and by the Rheumatology Department of Pontificia Universidad Católica de Chile. J. Durán, MD, MS, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; L. Massardo, MD, Centro de Biología Celular y Biomedicina, Facultad de Medicina y Ciencia, Universidad San Sebastián; C. Llanos, MD, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; S. Iacobelli, MD, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; P.I. Burgos, MD, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; M. Cisternas, MD, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; M. Iruretagoyena, MD, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; M. Armstrong, MD, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; R. Aguilera, MD, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; F. Radrigán, MD, Hospital Dr. Sótero del Río, Pontificia Universidad Católica de Chile; M.E. Martinez, MD, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; A. Passi-Solar, MS, Department of Epidemiology and Public Health, University College London, and Department of Public Health, School of Medicine, Pontificia Universidad Católica de Chile; P. Riedemann, MD, MPH, Department of Rheumatology, School of Medicine, Universidad de la Frontera; N. Crisóstomo, School of Medicine, Pontificia Universidad Católica de Chile; C. Cifuentes, MD, School of Medicine, Pontificia Universidad Católica de Chile; L. Hagedorn, School of Medicine, Pontificia Universidad Católica de Chile; A. Cisternas, MD, School of Medicine, Pontificia Universidad Católica de Chile; N. Vasquez, RN, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; P. Margozzini, MD, MPH, Department of Epidemiology and Public Health, University College London. Address correspondence to Drs. J. Durán and P. Margozzini, Diagonal Paraguay 362, 6th floor, Santiago Centro, Santiago, Chile. E-mail: jgduran@uc.cl, pmargoz@med.puc.cl. Accepted for publication August 22, 2019.
Camila Cifuentes
From the Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile, Santiago; Centro de Biología Celular y Biomedicina, Facultad de Medicina y Ciencia, Universidad San Sebastián, Santiago; Hospital Dr. Sótero del Río, Pontificia Universidad Católica de Chile, Santiago; Department of Public Health, School of Medicine, Pontificia Universidad Católica de Chile, Santiago; Department of Rheumatology, School of Medicine, Universidad de la Frontera, Temuco, Chile; Department of Epidemiology and Public Health, University College London, London, UK. Funded by the Chilean Ministry of Health (MINSAL) and by the Rheumatology Department of Pontificia Universidad Católica de Chile. J. Durán, MD, MS, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; L. Massardo, MD, Centro de Biología Celular y Biomedicina, Facultad de Medicina y Ciencia, Universidad San Sebastián; C. Llanos, MD, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; S. Iacobelli, MD, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; P.I. Burgos, MD, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; M. Cisternas, MD, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; M. Iruretagoyena, MD, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; M. Armstrong, MD, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; R. Aguilera, MD, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; F. Radrigán, MD, Hospital Dr. Sótero del Río, Pontificia Universidad Católica de Chile; M.E. Martinez, MD, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; A. Passi-Solar, MS, Department of Epidemiology and Public Health, University College London, and Department of Public Health, School of Medicine, Pontificia Universidad Católica de Chile; P. Riedemann, MD, MPH, Department of Rheumatology, School of Medicine, Universidad de la Frontera; N. Crisóstomo, School of Medicine, Pontificia Universidad Católica de Chile; C. Cifuentes, MD, School of Medicine, Pontificia Universidad Católica de Chile; L. Hagedorn, School of Medicine, Pontificia Universidad Católica de Chile; A. Cisternas, MD, School of Medicine, Pontificia Universidad Católica de Chile; N. Vasquez, RN, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; P. Margozzini, MD, MPH, Department of Epidemiology and Public Health, University College London. Address correspondence to Drs. J. Durán and P. Margozzini, Diagonal Paraguay 362, 6th floor, Santiago Centro, Santiago, Chile. E-mail: jgduran@uc.cl, pmargoz@med.puc.cl. Accepted for publication August 22, 2019.
Lucero Hagedorn
From the Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile, Santiago; Centro de Biología Celular y Biomedicina, Facultad de Medicina y Ciencia, Universidad San Sebastián, Santiago; Hospital Dr. Sótero del Río, Pontificia Universidad Católica de Chile, Santiago; Department of Public Health, School of Medicine, Pontificia Universidad Católica de Chile, Santiago; Department of Rheumatology, School of Medicine, Universidad de la Frontera, Temuco, Chile; Department of Epidemiology and Public Health, University College London, London, UK. Funded by the Chilean Ministry of Health (MINSAL) and by the Rheumatology Department of Pontificia Universidad Católica de Chile. J. Durán, MD, MS, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; L. Massardo, MD, Centro de Biología Celular y Biomedicina, Facultad de Medicina y Ciencia, Universidad San Sebastián; C. Llanos, MD, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; S. Iacobelli, MD, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; P.I. Burgos, MD, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; M. Cisternas, MD, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; M. Iruretagoyena, MD, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; M. Armstrong, MD, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; R. Aguilera, MD, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; F. Radrigán, MD, Hospital Dr. Sótero del Río, Pontificia Universidad Católica de Chile; M.E. Martinez, MD, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; A. Passi-Solar, MS, Department of Epidemiology and Public Health, University College London, and Department of Public Health, School of Medicine, Pontificia Universidad Católica de Chile; P. Riedemann, MD, MPH, Department of Rheumatology, School of Medicine, Universidad de la Frontera; N. Crisóstomo, School of Medicine, Pontificia Universidad Católica de Chile; C. Cifuentes, MD, School of Medicine, Pontificia Universidad Católica de Chile; L. Hagedorn, School of Medicine, Pontificia Universidad Católica de Chile; A. Cisternas, MD, School of Medicine, Pontificia Universidad Católica de Chile; N. Vasquez, RN, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; P. Margozzini, MD, MPH, Department of Epidemiology and Public Health, University College London. Address correspondence to Drs. J. Durán and P. Margozzini, Diagonal Paraguay 362, 6th floor, Santiago Centro, Santiago, Chile. E-mail: jgduran@uc.cl, pmargoz@med.puc.cl. Accepted for publication August 22, 2019.
Alvaro Cisternas
From the Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile, Santiago; Centro de Biología Celular y Biomedicina, Facultad de Medicina y Ciencia, Universidad San Sebastián, Santiago; Hospital Dr. Sótero del Río, Pontificia Universidad Católica de Chile, Santiago; Department of Public Health, School of Medicine, Pontificia Universidad Católica de Chile, Santiago; Department of Rheumatology, School of Medicine, Universidad de la Frontera, Temuco, Chile; Department of Epidemiology and Public Health, University College London, London, UK. Funded by the Chilean Ministry of Health (MINSAL) and by the Rheumatology Department of Pontificia Universidad Católica de Chile. J. Durán, MD, MS, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; L. Massardo, MD, Centro de Biología Celular y Biomedicina, Facultad de Medicina y Ciencia, Universidad San Sebastián; C. Llanos, MD, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; S. Iacobelli, MD, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; P.I. Burgos, MD, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; M. Cisternas, MD, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; M. Iruretagoyena, MD, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; M. Armstrong, MD, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; R. Aguilera, MD, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; F. Radrigán, MD, Hospital Dr. Sótero del Río, Pontificia Universidad Católica de Chile; M.E. Martinez, MD, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; A. Passi-Solar, MS, Department of Epidemiology and Public Health, University College London, and Department of Public Health, School of Medicine, Pontificia Universidad Católica de Chile; P. Riedemann, MD, MPH, Department of Rheumatology, School of Medicine, Universidad de la Frontera; N. Crisóstomo, School of Medicine, Pontificia Universidad Católica de Chile; C. Cifuentes, MD, School of Medicine, Pontificia Universidad Católica de Chile; L. Hagedorn, School of Medicine, Pontificia Universidad Católica de Chile; A. Cisternas, MD, School of Medicine, Pontificia Universidad Católica de Chile; N. Vasquez, RN, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; P. Margozzini, MD, MPH, Department of Epidemiology and Public Health, University College London. Address correspondence to Drs. J. Durán and P. Margozzini, Diagonal Paraguay 362, 6th floor, Santiago Centro, Santiago, Chile. E-mail: jgduran@uc.cl, pmargoz@med.puc.cl. Accepted for publication August 22, 2019.
Nancy Vasquez
From the Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile, Santiago; Centro de Biología Celular y Biomedicina, Facultad de Medicina y Ciencia, Universidad San Sebastián, Santiago; Hospital Dr. Sótero del Río, Pontificia Universidad Católica de Chile, Santiago; Department of Public Health, School of Medicine, Pontificia Universidad Católica de Chile, Santiago; Department of Rheumatology, School of Medicine, Universidad de la Frontera, Temuco, Chile; Department of Epidemiology and Public Health, University College London, London, UK. Funded by the Chilean Ministry of Health (MINSAL) and by the Rheumatology Department of Pontificia Universidad Católica de Chile. J. Durán, MD, MS, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; L. Massardo, MD, Centro de Biología Celular y Biomedicina, Facultad de Medicina y Ciencia, Universidad San Sebastián; C. Llanos, MD, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; S. Iacobelli, MD, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; P.I. Burgos, MD, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; M. Cisternas, MD, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; M. Iruretagoyena, MD, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; M. Armstrong, MD, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; R. Aguilera, MD, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; F. Radrigán, MD, Hospital Dr. Sótero del Río, Pontificia Universidad Católica de Chile; M.E. Martinez, MD, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; A. Passi-Solar, MS, Department of Epidemiology and Public Health, University College London, and Department of Public Health, School of Medicine, Pontificia Universidad Católica de Chile; P. Riedemann, MD, MPH, Department of Rheumatology, School of Medicine, Universidad de la Frontera; N. Crisóstomo, School of Medicine, Pontificia Universidad Católica de Chile; C. Cifuentes, MD, School of Medicine, Pontificia Universidad Católica de Chile; L. Hagedorn, School of Medicine, Pontificia Universidad Católica de Chile; A. Cisternas, MD, School of Medicine, Pontificia Universidad Católica de Chile; N. Vasquez, RN, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; P. Margozzini, MD, MPH, Department of Epidemiology and Public Health, University College London. Address correspondence to Drs. J. Durán and P. Margozzini, Diagonal Paraguay 362, 6th floor, Santiago Centro, Santiago, Chile. E-mail: jgduran@uc.cl, pmargoz@med.puc.cl. Accepted for publication August 22, 2019.
Paula Margozzini
From the Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile, Santiago; Centro de Biología Celular y Biomedicina, Facultad de Medicina y Ciencia, Universidad San Sebastián, Santiago; Hospital Dr. Sótero del Río, Pontificia Universidad Católica de Chile, Santiago; Department of Public Health, School of Medicine, Pontificia Universidad Católica de Chile, Santiago; Department of Rheumatology, School of Medicine, Universidad de la Frontera, Temuco, Chile; Department of Epidemiology and Public Health, University College London, London, UK. Funded by the Chilean Ministry of Health (MINSAL) and by the Rheumatology Department of Pontificia Universidad Católica de Chile. J. Durán, MD, MS, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; L. Massardo, MD, Centro de Biología Celular y Biomedicina, Facultad de Medicina y Ciencia, Universidad San Sebastián; C. Llanos, MD, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; S. Iacobelli, MD, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; P.I. Burgos, MD, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; M. Cisternas, MD, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; M. Iruretagoyena, MD, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; M. Armstrong, MD, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; R. Aguilera, MD, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; F. Radrigán, MD, Hospital Dr. Sótero del Río, Pontificia Universidad Católica de Chile; M.E. Martinez, MD, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; A. Passi-Solar, MS, Department of Epidemiology and Public Health, University College London, and Department of Public Health, School of Medicine, Pontificia Universidad Católica de Chile; P. Riedemann, MD, MPH, Department of Rheumatology, School of Medicine, Universidad de la Frontera; N. Crisóstomo, School of Medicine, Pontificia Universidad Católica de Chile; C. Cifuentes, MD, School of Medicine, Pontificia Universidad Católica de Chile; L. Hagedorn, School of Medicine, Pontificia Universidad Católica de Chile; A. Cisternas, MD, School of Medicine, Pontificia Universidad Católica de Chile; N. Vasquez, RN, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; P. Margozzini, MD, MPH, Department of Epidemiology and Public Health, University College London. Address correspondence to Drs. J. Durán and P. Margozzini, Diagonal Paraguay 362, 6th floor, Santiago Centro, Santiago, Chile. E-mail: jgduran@uc.cl, pmargoz@med.puc.cl. Accepted for publication August 22, 2019.
From the Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile, Santiago; Centro de Biología Celular y Biomedicina, Facultad de Medicina y Ciencia, Universidad San Sebastián, Santiago; Hospital Dr. Sótero del Río, Pontificia Universidad Católica de Chile, Santiago; Department of Public Health, School of Medicine, Pontificia Universidad Católica de Chile, Santiago; Department of Rheumatology, School of Medicine, Universidad de la Frontera, Temuco, Chile; Department of Epidemiology and Public Health, University College London, London, UK. Funded by the Chilean Ministry of Health (MINSAL) and by the Rheumatology Department of Pontificia Universidad Católica de Chile. J. Durán, MD, MS, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; L. Massardo, MD, Centro de Biología Celular y Biomedicina, Facultad de Medicina y Ciencia, Universidad San Sebastián; C. Llanos, MD, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; S. Iacobelli, MD, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; P.I. Burgos, MD, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; M. Cisternas, MD, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; M. Iruretagoyena, MD, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; M. Armstrong, MD, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; R. Aguilera, MD, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; F. Radrigán, MD, Hospital Dr. Sótero del Río, Pontificia Universidad Católica de Chile; M.E. Martinez, MD, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; A. Passi-Solar, MS, Department of Epidemiology and Public Health, University College London, and Department of Public Health, School of Medicine, Pontificia Universidad Católica de Chile; P. Riedemann, MD, MPH, Department of Rheumatology, School of Medicine, Universidad de la Frontera; N. Crisóstomo, School of Medicine, Pontificia Universidad Católica de Chile; C. Cifuentes, MD, School of Medicine, Pontificia Universidad Católica de Chile; L. Hagedorn, School of Medicine, Pontificia Universidad Católica de Chile; A. Cisternas, MD, School of Medicine, Pontificia Universidad Católica de Chile; N. Vasquez, RN, Department of Rheumatology, School of Medicine, Pontificia Universidad Católica de Chile; P. Margozzini, MD, MPH, Department of Epidemiology and Public Health, University College London. Address correspondence to Drs. J. Durán and P. Margozzini, Diagonal Paraguay 362, 6th floor, Santiago Centro, Santiago, Chile. E-mail: jgduran@uc.cl, pmargoz@med.puc.cl. Accepted for publication August 22, 2019.
Data supplements
Data Supplement
In this issue
The Journal of Rheumatology
Vol. 51, Issue 4
1 Apr 2024
The Prevalence of Rheumatoid Arthritis in Chile: A Nationwide Study Performed as Part of the National Health Survey
Josefina Durán, Loreto Massardo, Carolina Llanos, Sergio Iacobelli, Paula Burgos, Marcela Cisternas, Mirentxu Iruretagoyena, Macarena Armstrong, Raquel Aguilera, Francisco Radrigán, María Eugenia Martinez, Alvaro Passi-Solar, Pablo Riedemann, Natalia Crisóstomo, Camila Cifuentes, Lucero Hagedorn, Alvaro Cisternas, Nancy Vasquez, Paula Margozzini, the ENS2017 Study Group
The Journal of Rheumatology Sep 2019, jrheum.190396; DOI: 10.3899/jrheum.190396
The Prevalence of Rheumatoid Arthritis in Chile: A Nationwide Study Performed as Part of the National Health Survey
Josefina Durán, Loreto Massardo, Carolina Llanos, Sergio Iacobelli, Paula Burgos, Marcela Cisternas, Mirentxu Iruretagoyena, Macarena Armstrong, Raquel Aguilera, Francisco Radrigán, María Eugenia Martinez, Alvaro Passi-Solar, Pablo Riedemann, Natalia Crisóstomo, Camila Cifuentes, Lucero Hagedorn, Alvaro Cisternas, Nancy Vasquez, Paula Margozzini, the ENS2017 Study Group
The Journal of Rheumatology Sep 2019, jrheum.190396; DOI: 10.3899/jrheum.190396